Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
123.329 0.1 (0.08%)

NAV as on 28 Jun, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (May 31, 17)
Equity Sector Value
(Rs cr)
Assets %
Strides Shasun Pharmaceuticals 81.46 9.62
Lupin Pharmaceuticals 69.66 8.22
Aurobindo Pharm Pharmaceuticals 57.42 6.78
Cipla Pharmaceuticals 51.64 6.09
Divis Labs Pharmaceuticals 43.66 5.15
Thyrocare Techn Services 39.36 4.65
Natco Pharma Pharmaceuticals 37.35 4.41
Torrent Pharma Pharmaceuticals 37.00 4.37
Sun Pharma Pharmaceuticals 35.11 4.14
Cadila Health Pharmaceuticals 34.81 4.11
Sector Allocation (May 31, 17)
  Sector   % 1-Year
High Low

Pharmaceuticals

84.25 0.00 0.00

Services

9.85 0.00 0.00
Asset Allocation (%) (May 31, 17)
Class
%

Equity

94.10

Others / Unlisted

0.11

Debt

0.00

Mutual Funds

N.A

Money Market

9.17

Cash / Call

-3.38

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

35.86

Top 10

57.54
Sectors
%

Top 3

94.10
Sections
Follow us on
Available On